Development of a selective modulator of aryl hydrocarbon (Ah) receptor activity that exhibits anti-inflammatory properties

Chemical Research in Toxicology

Volumn 23, Issue 5, 2010, Pages 955-966

  Murray, Iain A ^a   Krishnegowda, Gowdahalli ^b   Dinatale, Brett C ^a   Flaveny, Colin ^a   Chiaro, Chris ^a   Lin, Jyh Ming ^b   Sharma, Arun K ^b   Amin, Shantu ^b   Perdew, Gary H ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 ALLYL 7 TRIFLUOROMETHYL 1H INDAZOL 3 YL 4 METHOXYPHENOL; 2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; ANTIINFLAMMATORY AGENT; AROMATIC HYDROCARBON RECEPTOR; ESTROGEN RECEPTOR; INDAZOLE DERIVATIVE; PHORBOL 13 ACETATE 12 MYRISTATE; SGA 360; UNCLASSIFIED DRUG; WAY 169916;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG SYNTHESIS; EDEMA; GENE EXPRESSION; MALE; MOUSE; NONHUMAN; OTITIS;

ALLYL COMPOUNDS; ANIMALS; ANTI-INFLAMMATORY AGENTS; CYCLOOXYGENASE 2; GENE EXPRESSION REGULATION; HEP G2 CELLS; HUMANS; INDAZOLES; INTERLEUKIN-6; LIGANDS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OTITIS; PYRAZOLES; RECEPTORS, ARYL HYDROCARBON; RECEPTORS, ESTROGEN; RNA, MESSENGER; SERUM AMYLOID A PROTEIN; TETRADECANOYLPHORBOL ACETATE;

MUS;

EID: 77952376152     PISSN: 0893228X     EISSN: 15205010     Source Type: Journal    
DOI: 10.1021/tx100045h     Document Type: Article

References (43)

1. Gabay, C. and Kushner, I. (1999) Acute-phase proteins and other systemic responses to inflammation N. Engl. J. Med. 340, 448-454
2. Cheng, N., He, R., Tian, J., Ye, P. P., and Ye, R. D. (2008) Cutting edge: TLR2 is a functional receptor for acute-phase serum amyloid A J. Immunol. 181, 22-26
3. Okamoto, H., Katagiri, Y., Kiire, A., Momohara, S., and Kamatani, N. (2008) Serum amyloid A activates nuclear factor-kappaB in rheumatoid synovial fibroblasts through binding to receptor of advanced glycation end-products J. Rheumatol. 35, 752-756
4. Lee, M. S., Yoo, S. A., Cho, C. S., Suh, P. G., Kim, W. U., and Ryu, S. H. (2006) Serum amyloid A binding to formyl peptide receptor-like 1 induces synovial hyperplasia and angiogenesis J. Immunol. 177, 5585-5594
5. Yan, S. D., Zhu, H., Zhu, A., Golabek, A., Du, H., Roher, A., Yu, J., Soto, C., Schmidt, A. M., Stern, D., and Kindy, M. (2000) Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis Nat. Med. 6, 643-651
6. Beischlag, T. V., Luis Morales, J., Hollingshead, B. D., and Perdew, G. H. (2008) The aryl hydrocarbon receptor complex and the control of gene expression Crit. Rev. Eukaryotic Gene Expression 18, 207-250
7. McMillan, B. J. and Bradfield, C. A. (2007) The aryl hydrocarbon receptor sans xenobiotics: endogenous function in genetic model systems Mol. Pharmacol. 72, 487-498
8. Baba, T., Mimura, J., Nakamura, N., Harada, N., Yamamoto, M., Morohashi, K., and Fujii-Kuriyama, Y. (2005) Intrinsic function of the aryl hydrocarbon (dioxin) receptor as a key factor in female reproduction Mol. Cell. Biol. 25, 10040-10051
9. Barnett, K. R., Tomic, D., Gupta, R. K., Miller, K. P., Meachum, S., Paulose, T., and Flaws, J. A. (2007) The aryl hydrocarbon receptor affects mouse ovarian follicle growth via mechanisms involving estradiol regulation and responsiveness Biol. Reprod. 76, 1062-1070
10. Lund, A. K., Agbor, L. N., Zhang, N., Baker, A., Zhao, H., Fink, G. D., Kanagy, N. L., and Walker, M. K. (2008) Loss of the aryl hydrocarbon receptor induces hypoxemia, endothelin-1, and systemic hypertension at modest altitude Hypertension 51, 803-809
11. Negishi, T., Kato, Y., Ooneda, O., Mimura, J., Takada, T., Mochizuki, H., Yamamoto, M., Fujii-Kuriyama, Y., and Furusako, S. (2005) Effects of aryl hydrocarbon receptor signaling on the modulation of TH1/TH2 balance J. Immunol. 175, 7348-7356
12. Morales, J. L., Krzeminski, J., Amin, S., and Perdew, G. H. (2008) Characterization of the antiallergic drugs 3-[2-(2-phenylethyl) benzoimidazole-4-yl]-3-hydroxypropanoic acid and ethyl 3-hydroxy-3-[2-(2- phenylethyl)benzoimidazol-4-yl]propanoate as full aryl hydrocarbon receptor agonists Chem. Res. Toxicol. 21, 472-482
13. Peck, A. and Mellins, E. D. (2009) Breaking old paradigms: Th17 cells in autoimmune arthritis Clin. Immunol. 132, 295-304
14. Veldhoen, M., Hirota, K., Westendorf, A. M., Buer, J., Dumoutier, L., Renauld, J. C., and Stockinger, B. (2008) The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins Nature 453, 106-109
15. Veldhoen, M., Hirota, K., Christensen, J., OGarra, A., and Stockinger, B. (2009) Natural agonists for aryl hydrocarbon receptor in culture medium are essential for optimal differentiation of Th17 T cells J. Exp. Med. 206, 43-49
16. Kimura, A., Naka, T., Nohara, K., Fujii-Kuriyama, Y., and Kishimoto, T. (2008) Aryl hydrocarbon receptor regulates Stat1 activation and participates in the development of Th17 cells Proc. Natl. Acad. Sci. U.S.A. 105, 9721-9726
17. Kitamura, M. and Kasai, A. (2007) Cigarette smoke as a trigger for the dioxin receptor-mediated signaling pathway Cancer Lett. 252, 184-194
18. Tian, Y., Ke, S., Denison, M. S., Rabson, A. B., and Gallo, M. A. (1999) Ah receptor and NF-kappaB interactions, a potential mechanism for dioxin toxicity J. Biol. Chem. 274, 510-515
19. Jensen, B. A., Leeman, R. J., Schlezinger, J. J., and Sherr, D. H. (2003) Aryl hydrocarbon receptor (AhR) agonists suppress interleukin-6 expression by bone marrow stromal cells: an immunotoxicology study Environ. Health 2, 16
20. Patel, R. D., Murray, I. A., Flaveny, C. A., Kusnadi, A., and Perdew, G. H. (2009) Ah receptor represses acute-phase response gene expression without binding to its cognate response element Lab. Invest. 89, 695-707
21. Bunger, M. K., Glover, E., Moran, S. M., Walisser, J. A., Lahvis, G. P., Hsu, E. L., and Bradfield, C. A. (2008) Abnormal liver development and resistance to 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity in mice carrying a mutation in the DNA-binding domain of the aryl hydrocarbon receptor Toxicol. Sci. 106, 83-92
22. Murray, I. A., Morales, J. L., Flaveny, C. A., Dinatale, B. C., Chiaro, C., Gowdahalli, K., Amin, S., and Perdew, G. H. (2010) Evidence for ligand-mediated selective modulation of aryl hydrocarbon receptor activity Mol. Pharmacol. 77, 247-254
23. Steffan, R. J., Matelan, E., Ashwell, M. A., Moore, W. J., Solvibile, W. R., Trybulski, E., Chadwick, C. C., Chippari, S., Kenney, T., Eckert, A., Borges-Marcucci, L., Keith, J. C., Xu, Z., Mosyak, L., and Harnish, D. C. (2004) Synthesis and activity of substituted 4-(indazol-3-yl)phenols as pathway-selective estrogen receptor ligands useful in the treatment of rheumatoid arthritis J. Med. Chem. 47, 6435-6438
24. Long, W. P., Pray-Grant, M., Tsai, J. C., and Perdew, G. H. (1998) Protein kinase C activity is required for aryl hydrocarbon receptor pathway-mediated signal transduction Mol. Pharmacol. 53, 691-700
25. Garrison, P. M., Tullis, K., Aarts, J. M., Brouwer, A., Giesy, J. P., and Denison, M. S. (1996) Species-specific recombinant cell lines as bioassay systems for the detection of 2,3,7,8-tetrachlorodibenzo-p-dioxin-like chemicals Fundam. Appl. Toxicol. 30, 194-203
26. Poland, A., Glover, E., Ebetino, H., and Kende, A. (1986) Photoaffinity labelling of the Ah receptor Food Chem. Toxicol. 24, 781-787
27. Ramadoss, P. and Perdew, G. H. (2004) Use of 2-azido-3-[125I]iodo-7,8- dibromodibenzo-p-dioxin as a probe to determine the relative ligand affinity of human versus mouse aryl hydrocarbon receptor in cultured cells Mol. Pharmacol. 66, 129-136
28. Flaveny, C. A., Murray, I. A., Chiaro, C. R., and Perdew, G. H. (2009) Ligand selectivity and gene regulation by the human aryl hydrocarbon receptor in transgenic mice Mol. Pharmacol. 75, 1412-1420
29. Nahm, S. and Weinreb, S. M. (1981) N-methoxy-N-methylamides as effective acylating agents Tetrahedron Lett. 22, 3815-3818
30. De Luca, L., Giacomelli, G., and Taddei, M. (2001) An easy and convenient synthesis of Weinreb amides and hydroxamates J. Org. Chem. 66, 2534-2537
31. Chadwick, C. C., Chippari, S., Matelan, E., Borges-Marcucci, L., Eckert, A. M., Keith, J. C., Jr., Albert, L. M., Leathurby, Y., Harris, H. A., Bhat, R. A., Ashwell, M., Trybulski, E., Winneker, R. C., Adelman, S. J., Steffan, R. J., and Harnish, D. C. (2005) Identification of pathway-selective estrogen receptor ligands that inhibit NF-kappaB transcriptional activity Proc. Natl. Acad. Sci. U.S.A. 102, 2543-2548
32. Zhang, S., Qin, C., and Safe, S. H. (2003) Flavonoids as aryl hydrocarbon receptor agonists/antagonists: effects of structure and cell context Environ. Health Perspect. 111, 1877-1882
33. Schacke, H., Schottelius, A., Docke, W. D., Strehlke, P., Jaroch, S., Schmees, N., Rehwinkel, H., Hennekes, H., and Asadullah, K. (2004) Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects Proc. Natl. Acad. Sci. U.S.A. 101, 227-232
34. Keith, J. C., Jr., Albert, L. M., Leathurby, Y., Follettie, M., Wang, L., Borges-Marcucci, L., Chadwick, C. C., Steffan, R. J., and Harnish, D. C. (2005) The utility of pathway selective estrogen receptor ligands that inhibit nuclear factor-kappa B transcriptional activity in models of rheumatoid arthritis Arthritis Res. Ther. 7, R427-4R38
35. Shi, L. Z., Faith, N. G., Nakayama, Y., Suresh, M., Steinberg, H., and Czuprynski, C. J. (2007) The aryl hydrocarbon receptor is required for optimal resistance to Listeria monocytogenes infection in mice J. Immunol. 179, 6952-6962
36. De Souza, V. R., Cabrera, W. K., Galvan, A., Ribeiro, O. G., De Franco, M., Vorraro, F., Starobinas, N., Massa, S., Dragani, T. A., and Ibanez, O. M. (2009) Aryl hydrocarbon receptor polymorphism modulates DMBA-induced inflammation and carcinogenesis in phenotypically selected mice Int. J. Cancer 124, 1478-1482
37. De Young, L. M., Kheifets, J. B., Ballaron, S. J., and Young, J. M. (1989) Edema and cell infiltration in the phorbol ester-treated mouse ear are temporally separate and can be differentially modulated by pharmacologic agents Agents Actions 26, 335-341
38. Chiaro, C. R., Patel, R. D., and Perdew, G. H. (2008) 12(R)-Hydroxy-5(Z),8(Z),10(E),14(Z)-eicosatetraenoic acid [12(R)-HETE], an arachidonic acid derivative, is an activator of the aryl hydrocarbon receptor Mol. Pharmacol. 74, 1649-1656
39. Tauchi, M., Hida, A., Negishi, T., Katsuoka, F., Noda, S., Mimura, J., Hosoya, T., Yanaka, A., Aburatani, H., Fujii-Kuriyama, Y., Motohashi, H., and Yamamoto, M. (2005) Constitutive expression of aryl hydrocarbon receptor in keratinocytes causes inflammatory skin lesions Mol. Cell. Biol. 25, 9360-9368
40. Hollingshead, B. D., Beischlag, T. V., Dinatale, B. C., Ramadoss, P., and Perdew, G. H. (2008) Inflammatory signaling and aryl hydrocarbon receptor mediate synergistic induction of interleukin 6 in MCF-7 cells Cancer Res. 68, 3609-3617
41. Beischlag, T. V. and Perdew, G. H. (2005) ER alpha-AHR-ARNT protein-protein interactions mediate estradiol-dependent transrepression of dioxin-inducible gene transcription J. Biol. Chem. 280, 21607-21611
42. Trifari, S., Kaplan, C. D., Tran, E. H., Crellin, N. K., and Spits, H. (2009) Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells Nat. Immunol. 10, 864-871
43. Zhang, S., Lei, P., Liu, X., Li, X., Walker, K., Kotha, L., Rowlands, C., and Safe, S. (2009) The aryl hydrocarbon receptor as a target for estrogen receptor-negative breast cancer chemotherapy Endocr. Relat. Cancer 16, 835-844